Recombinant human growth hormone in neonatal-onset multisystem inflammatory disease

Donato Rigante, Clelia Cipolla, Aurora Natalia Rossodivita

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

This report indicates that stunted growth as part of the neonatal-onset multisystem inflammatory disease (NOMID) clinical scenery can be related to the skeletal picture of the disease itself, but also to growth hormone deficiency and that a substantial response to recombinant human growth hormone can be observed in NOMID.
Original languageEnglish
Pages (from-to)101-105
Number of pages5
JournalClinical Pediatric Endocrinology
Volume2018
DOIs
Publication statusPublished - 2018

Keywords

  • Growth Hormone

Fingerprint

Dive into the research topics of 'Recombinant human growth hormone in neonatal-onset multisystem inflammatory disease'. Together they form a unique fingerprint.

Cite this